PPARG and neoplasm: Clinical studies revealed that PPARγ expression represents a positive prognostic factor in luminal and ductal breast cancer patients [15], since higher levels of PPARγ inversely correlate with grade, tumor size, and TNM staging system of malignant tumor [16,17].